Skip to main content
Back to Lux Capital

Lux Capital's Biotechnology Portfolio

Browse 9 Biotechnology companies funded by Lux Capital. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
9
Total Funding in Biotechnology
$572.5M

Biotechnology Portfolio Companies (9)

Export
BiotechnologyHealth CareLife ScienceMedicalTherapeutics

H1 is on a mission to connect the world to the right doctor

New York, United States
May 2026
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyComputer VisionMachine Learning

Optimizing cell therapy with spatial biology

New York, United States
May 2026
$14.5M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

Atavistik Bio is a biotechnology company that develops precision allosteric small molecules aimed at treating metabolic diseases and cancer.

Cambridge, United States
March 2026
$40.0M
Series B

Founder Contacts

19,000+ verified contacts

Biotechnology

Until Labs is advancing technology to pause biological time, with a dedicated in-house team of biologists, engineers, and physicists.

San Francisco, United States
September 2025
$58.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

Enveda Biosciences is a biotechnology company that develops novel medications derived from plants.

Boulder, United States
September 2025
$150.0M
Series D

Founder Contacts

19,000+ verified contacts

BiotechnologyLife SciencePharmaceutical

Atrandi Biosciences is a Lithuanian biotech startup that aims to commercialize droplet microfluidics technology.

Vilnius, Lithuania
February 2025
$25.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth DiagnosticsMarket ResearchNanotechnology

Nomic develops a proteomic technology platform to understand, detect, and treat diseases with DNA nanotechnology.

Montréal, Canada
September 2024
$42.0M
Series B

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BioinformaticsBiotechnologyHealth Care

EvolutionaryScale is a developer of biological artificial intelligence models for therapeutic design.

New York, United States
June 2024
$142.0M
Seed

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareTherapeuticsWellness

NILO Therapeutics is a biotechnology and therapeutics company.

New York, United States
October 2025
$101.0M
Series A

Founder Contacts

19,000+ verified contacts

Explore Lux Capital's Full Portfolio

View all companies funded by Lux Capital across every industry and funding stage.

View Full Lux Capital Portfolio